Season 2 (2021-2030)

Ophthalmology - Phase2 (1)

Modality Indication Targets Stage Company Project No. Detail
1 Future Medicine FM101-Oral Glaucoma Treatment
Small Molecules Glaucoma, Ocular hypertension A3AR Phase 2 Future Medicine Co., Ltd. HN22C0520
BACK